Biocardia Stock Technical Analysis
| BCDA Stock | USD 1.30 0.02 1.52% |
As of the 29th of January, Biocardia shows the insignificant Risk Adjusted Performance, mean deviation of 2.61, and Standard Deviation of 3.56. Biocardia technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Biocardia Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biocardia, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BiocardiaBiocardia | Build AI portfolio with Biocardia Stock |
Biocardia Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 15.5 | Strong Buy | 1 | Odds |
Most Biocardia analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biocardia stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biocardia, talking to its executives and customers, or listening to Biocardia conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biocardia. Projected growth potential of Biocardia fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Biocardia assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Biocardia requires distinguishing between market price and book value, where the latter reflects Biocardia's accounting equity. The concept of intrinsic value—what Biocardia's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Biocardia's price substantially above or below its fundamental value.
It's important to distinguish between Biocardia's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biocardia should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biocardia's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Biocardia 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biocardia's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biocardia.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Biocardia on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Biocardia or generate 0.0% return on investment in Biocardia over 90 days. Biocardia is related to or competes with Creative Medical, Aprea Therapeutics, Acurx Pharmaceuticals, Kiora Pharmaceuticals, HCW Biologics, Alzamend Neuro, and Adial Pharmaceuticals. BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for car... More
Biocardia Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biocardia's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biocardia upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 21.46 | |||
| Value At Risk | (5.76) | |||
| Potential Upside | 5.93 |
Biocardia Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biocardia's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biocardia's standard deviation. In reality, there are many statistical measures that can use Biocardia historical prices to predict the future Biocardia's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | (0.05) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biocardia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biocardia January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.04) | |||
| Mean Deviation | 2.61 | |||
| Coefficient Of Variation | (7,133) | |||
| Standard Deviation | 3.56 | |||
| Variance | 12.67 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | (0.05) | |||
| Maximum Drawdown | 21.46 | |||
| Value At Risk | (5.76) | |||
| Potential Upside | 5.93 | |||
| Skewness | 0.1708 | |||
| Kurtosis | 1.39 |
Biocardia Backtested Returns
Biocardia secures Sharpe Ratio (or Efficiency) of -0.0222, which signifies that the company had a -0.0222 % return per unit of risk over the last 3 months. Biocardia exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biocardia's insignificant Risk Adjusted Performance, mean deviation of 2.61, and Standard Deviation of 3.56 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.29, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biocardia will likely underperform. At this point, Biocardia has a negative expected return of -0.0708%. Please make sure to confirm Biocardia's skewness, day typical price, and the relationship between the treynor ratio and rate of daily change , to decide if Biocardia performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.69 |
Good predictability
Biocardia has good predictability. Overlapping area represents the amount of predictability between Biocardia time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biocardia price movement. The serial correlation of 0.69 indicates that around 69.0% of current Biocardia price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.69 | |
| Spearman Rank Test | 0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Biocardia technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Biocardia Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Biocardia across different markets.
About Biocardia Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biocardia on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biocardia based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Biocardia price pattern first instead of the macroeconomic environment surrounding Biocardia. By analyzing Biocardia's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biocardia's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biocardia specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.0338 | 0.03 | Price To Sales Ratio | 118.61 | 230.96 |
Biocardia January 29, 2026 Technical Indicators
Most technical analysis of Biocardia help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biocardia from various momentum indicators to cycle indicators. When you analyze Biocardia charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.04) | |||
| Mean Deviation | 2.61 | |||
| Coefficient Of Variation | (7,133) | |||
| Standard Deviation | 3.56 | |||
| Variance | 12.67 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | (0.05) | |||
| Maximum Drawdown | 21.46 | |||
| Value At Risk | (5.76) | |||
| Potential Upside | 5.93 | |||
| Skewness | 0.1708 | |||
| Kurtosis | 1.39 |
Biocardia January 29, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Biocardia stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 1.30 | ||
| Day Typical Price | 1.30 | ||
| Price Action Indicator | (0.01) |
Complementary Tools for Biocardia Stock analysis
When running Biocardia's price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |